Publications by authors named "A Di Bon"
Article Synopsis
- Heart transplant patients with donor-specific antibodies (DSAs) face a higher risk of rejection, but some do not show antibody-mediated rejection despite having graft dysfunction.
- A study involved 216 participants undergoing serial evaluations like endomyocardial biopsy (EMB) and echocardiograms to understand the relationship between DSAs, rejection types, and long-term outcomes.
- Results indicated that both antibody-mediated rejection (pAMR+) and DSA-related left ventricle dysfunction significantly correlated with increased mortality and prolonged heart dysfunction, particularly if they occurred within the first six months after transplant.
Article Synopsis
- * Researchers looked at the effects of GLP-1R agonists on the HPA axis and cortisol levels in individuals with varying responses to the treatment using advanced imaging techniques.
- * Results showed that pituitary GLP-1R expression was present in all participants, and while there were some differences by sex, the study concluded that HPA axis stimulation doesn't explain why some people poorly respond to GLP-1R agonists, suggesting the need for more research.
Introduction: Pregnant women with a history of metabolic bariatric surgery (MBS) are at high risk of developing nutrient deficiencies, leading to greater challenges to reach nutritional requirements. This study compared nutrient status of women using specialized "weight loss surgery" multivitamin supplementation (WLS-MVS) to those using standard supplementation (sMVS) during pregnancy following MBS.
Methods: Multicenter observational cohort study including 119 pregnant women at 41.
Introduction: In this phase 4, multicentre, prospective, non-interventional PIONEER REAL Netherlands study, we assessed clinical outcomes associated with once-daily oral semaglutide use in real-world clinical practice in adults living with type 2 diabetes (T2D) naïve to injectable glucose-lowering medication.
Methods: Participants initiated on oral semaglutide were followed for 34-44 weeks. Change in glycated haemoglobin (HbA1c) from baseline (BL) to end of study (EOS) was the primary endpoint; secondary endpoints included change in body weight (BW) from BL to EOS, the proportion of participants with HbA1c < 7.
Background: Management of insulin administration for intake of carbohydrates and physical activity can be burdensome for people with type 1 diabetes on hybrid closed-loop systems. Bihormonal fully closed-loop (FCL) systems could help reduce this burden. In this trial, we assessed the long-term performance and safety of a bihormonal FCL system.
View Article and Find Full Text PDF